Amwill Healthcare, one of India’s fastest-growing companies in the dermatology, trichology, and cosmetology sectors, has emerged as a leader with its innovative products and technology-driven approach. They offer solutions based on natural ingredients, allopathic actives, and advanced dermatology techniques, which provide effective and visible results. The company is now raising funds through its Book Built Issue, with an issue size of ₹59.97 Crores.

The Amwill Healthcare IPO consists of a fresh issue of 44.03 lakh shares worth ₹48.87 Crores and an Offer for Sale of 10.00 lakh shares worth ₹11.10 Crores. The subscription period for the IPO is from February 5, 2025, to February 7, 2025, with the listing date expected to be on February 12, 2025. The price band for the IPO has been set between ₹105 and ₹111 per equity share.

IPO Details:

• Subscription Period: February 5, 2025 – February 7, 2025
• IPO Price: ₹105 to ₹111 per share
• Market Capitalization: ₹222.04 Crores at the upper price band
• Lot Size: 1,200 shares (₹1,33,200 for retail investors)
• Minimum Investment: ₹1,33,200 for retail investors, ₹2,66,400 for High Net-Worth Individuals (HNIs)
• Listing Date: Expected on February 12, 2025

Grey Market Premium (GMP) and Subscription Status
As of February 6, 2025, the IPO is 1.15 times subscribed, showing moderate interest from investors. However, the Grey Market Premium (GMP) is currently ₹0, suggesting that no immediate listing gains are expected. The lack of a GMP indicates lower demand in the unorganized market for these shares.

IPO Allotment and How to Check Allotment Status
The allotment is expected to be finalized on February 10, 2025, and investors can easily check their status via the registrar’s website. Here's how:

1. Visit the IPO allotment status page.
2. Select Amwill Healthcare Limited IPO from the dropdown.
3. Enter your application number, PAN, or DP Client ID.
4. Submit the details to check your allotment status.

Objectives of the IPO
The IPO proceeds will be used for the following key objectives:

1. ₹2,500 Lakhs to meet the working capital requirements of the company.
2. ₹500 Lakhs for marketing and brand-building activities.
3. General corporate purposes to further enhance the company's operations.

Financial Performance and Analysis
Amwill Healthcare has shown strong financial growth over the years. For the period ending September 30, 2024, the company reported ₹2,324.71 Lakh in revenue, reflecting steady performance. The EBITDA has shown a jump to ₹893.04 Lakh, with a PAT of ₹651.66 Lakh for the same period, demonstrating healthy growth.

For FY24, the pre-issue EPS stands at ₹8.04, while the post-issue EPS is expected to be ₹6.27, with a P/E ratio of 13.81x (pre-issue) and 17.71x (post-issue). These figures indicate a relatively lower valuation compared to the industry P/E ratio of 36x. The ROCE of 94.16% and ROE of 73.06% suggest the company is efficiently utilizing its capital.

Investment Recommendations
The Amwill Healthcare IPO is attractively priced, and while the company is showing healthy growth, the Grey Market Premium of ₹0 indicates that the IPO may not yield immediate listing gains. We recommend cautious participation for investors with a long-term horizon, as the company is well-positioned in the expanding dermatology market.

The Upcoming IPOs in this week and coming weeks are Eleganz Interiors, PS Raj Steels, Chandan Healthcare, Ajax Engineering, Hexaware Technologies.

The Current active IPO are Readymix Construction, Solarium Green, Ken Enterprises, Amwill Healthcare,Chamunda Electricals.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.

Join our Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.